.elementor-widget.elementor-icon-list--layout-inline .elementor-widget-container{overflow:hidden}.elementor-widget .elementor-icon-list-items.elementor-inline-items{margin-right:-8px;margin-left:-8px}.elementor-widget .elementor-icon-list-items.elementor-inline-items .elementor-icon-list-item{margin-right:8px;margin-left:8px}.elementor-widget .elementor-icon-list-items.elementor-inline-items .elementor-icon-list-item:after{width:auto;left:auto;right:auto;position:relative;height:100%;border-top:0;border-bottom:0;border-right:0;border-left-width:1px;border-style:solid;left:-8px}.elementor-widget .elementor-icon-list-items{list-style-type:none;margin:0;padding:0}.elementor-widget .elementor-icon-list-item{margin:0;padding:0;position:relative}.elementor-widget .elementor-icon-list-item:after{position:absolute;bottom:0;width:100%}.elementor-widget .elementor-icon-list-item,.elementor-widget .elementor-icon-list-item a{display:-webkit-box;display:-ms-flexbox;display:flex;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-size:inherit}.elementor-widget .elementor-icon-list-icon+.elementor-icon-list-text{-ms-flex-item-align:center;align-self:center;padding-right:5px}.elementor-widget .elementor-icon-list-icon{display:-webkit-box;display:-ms-flexbox;display:flex}.elementor-widget .elementor-icon-list-icon svg{width:var(--e-icon-list-icon-size,1em);height:var(--e-icon-list-icon-size,1em)}.elementor-widget .elementor-icon-list-icon i{width:1.25em;font-size:var(--e-icon-list-icon-size)}.elementor-widget.elementor-widget-icon-list .elementor-icon-list-icon{text-align:var(--e-icon-list-icon-align)}.elementor-widget.elementor-widget-icon-list .elementor-icon-list-icon svg{margin:var(--e-icon-list-icon-margin,0 calc(var(--e-icon-list-icon-size, 1em) * .25) 0 0)}.elementor-widget.elementor-list-item-link-full_width a{width:100%}.elementor-widget.elementor-align-center .elementor-icon-list-item,.elementor-widget.elementor-align-center .elementor-icon-list-item a{-webkit-box-pack:center;-ms-flex-pack:center;justify-content:center}.elementor-widget.elementor-align-center .elementor-icon-list-item:after{margin:auto}.elementor-widget.elementor-align-center .elementor-inline-items{-webkit-box-pack:center;-ms-flex-pack:center;justify-content:center}.elementor-widget.elementor-align-left .elementor-icon-list-item,.elementor-widget.elementor-align-left .elementor-icon-list-item a{-webkit-box-pack:end;-ms-flex-pack:end;justify-content:flex-end;text-align:left}.elementor-widget.elementor-align-left .elementor-inline-items{-webkit-box-pack:end;-ms-flex-pack:end;justify-content:flex-end}.elementor-widget.elementor-align-right .elementor-icon-list-item,.elementor-widget.elementor-align-right .elementor-icon-list-item a{-webkit-box-pack:start;-ms-flex-pack:start;justify-content:flex-start;text-align:right}.elementor-widget.elementor-align-right .elementor-icon-list-items{-webkit-box-pack:start;-ms-flex-pack:start;justify-content:flex-start}.elementor-widget:not(.elementor-align-right) .elementor-icon-list-item:after{right:0}.elementor-widget:not(.elementor-align-left) .elementor-icon-list-item:after{left:0}@media (max-width:ELEMENTOR_SCREEN_TABLET_MAX){.elementor-widget.elementor-tablet-align-center .elementor-icon-list-item,.elementor-widget.elementor-tablet-align-center .elementor-icon-list-item a,.elementor-widget.elementor-tablet-align-center .elementor-icon-list-items{-webkit-box-pack:center;-ms-flex-pack:center;justify-content:center}.elementor-widget.elementor-tablet-align-center .elementor-icon-list-item:after{margin:auto}.elementor-widget.elementor-tablet-align-left .elementor-icon-list-items{-webkit-box-pack:end;-ms-flex-pack:end;justify-content:flex-end}.elementor-widget.elementor-tablet-align-left .elementor-icon-list-item,.elementor-widget.elementor-tablet-align-left .elementor-icon-list-item a{-webkit-box-pack:end;-ms-flex-pack:end;justify-content:flex-end;text-align:left}.elementor-widget.elementor-tablet-align-right .elementor-icon-list-items{-webkit-box-pack:start;-ms-flex-pack:start;justify-content:flex-start}.elementor-widget.elementor-tablet-align-right .elementor-icon-list-item,.elementor-widget.elementor-tablet-align-right .elementor-icon-list-item a{-webkit-box-pack:start;-ms-flex-pack:start;justify-content:flex-start;text-align:right}.elementor-widget:not(.elementor-tablet-align-right) .elementor-icon-list-item:after{right:0}.elementor-widget:not(.elementor-tablet-align-left) .elementor-icon-list-item:after{left:0}}@media (max-width:ELEMENTOR_SCREEN_MOBILE_MAX){.elementor-widget.elementor-mobile-align-center .elementor-icon-list-item,.elementor-widget.elementor-mobile-align-center .elementor-icon-list-item a,.elementor-widget.elementor-mobile-align-center .elementor-icon-list-items{-webkit-box-pack:center;-ms-flex-pack:center;justify-content:center}.elementor-widget.elementor-mobile-align-center .elementor-icon-list-item:after{margin:auto}.elementor-widget.elementor-mobile-align-left .elementor-icon-list-items{-webkit-box-pack:end;-ms-flex-pack:end;justify-content:flex-end}.elementor-widget.elementor-mobile-align-left .elementor-icon-list-item,.elementor-widget.elementor-mobile-align-left .elementor-icon-list-item a{-webkit-box-pack:end;-ms-flex-pack:end;justify-content:flex-end;text-align:left}.elementor-widget.elementor-mobile-align-right .elementor-icon-list-items{-webkit-box-pack:start;-ms-flex-pack:start;justify-content:flex-start}.elementor-widget.elementor-mobile-align-right .elementor-icon-list-item,.elementor-widget.elementor-mobile-align-right .elementor-icon-list-item a{-webkit-box-pack:start;-ms-flex-pack:start;justify-content:flex-start;text-align:right}.elementor-widget:not(.elementor-mobile-align-right) .elementor-icon-list-item:after{right:0}.elementor-widget:not(.elementor-mobile-align-left) .elementor-icon-list-item:after{left:0}}<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>psilocybin &#8211; Organic Kush FArms </title>
	<atom:link href="https://organickushfarm.com/tag/psilocybin/feed/" rel="self" type="application/rss+xml" />
	<link>https://organickushfarm.com</link>
	<description>buy weed online</description>
	<lastBuildDate>Sun, 15 Sep 2024 12:57:37 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://organickushfarm.com/wp-content/uploads/2024/04/cropped-OKF-32x32.png</url>
	<title>psilocybin &#8211; Organic Kush FArms </title>
	<link>https://organickushfarm.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Alaska Lawmaker Introduces Psychedelics Task Force Bill</title>
		<link>https://organickushfarm.com/psilocybin/</link>
					<comments>https://organickushfarm.com/psilocybin/#respond</comments>
		
		<dc:creator><![CDATA[eazecannabisdelivery]]></dc:creator>
		<pubDate>Mon, 11 Nov 2024 13:32:00 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[mushrooms]]></category>
		<category><![CDATA[Mushrooms Australia]]></category>
		<category><![CDATA[mushrooms USA]]></category>
		<category><![CDATA[psilocybin]]></category>
		<category><![CDATA[Psilocybin psychedelic drugs]]></category>
		<guid isPermaLink="false">http://organickushfarm.com/?p=4286</guid>

					<description><![CDATA[An Alaska lawmaker has introduced a bill to create a task force to study the potential medical uses of psychedelic drugs including psilocybin and MDMA. The legislation, Senate Bill 166, was introduced earlier this month by Democratic state Senator Forrest Dunbar. If passed by the legislature and signed into law by Republican Governor Mike Dunleavy,&#160;Dunbar’s [...]]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">An Alaska lawmaker has introduced a bill to create a task force to study the potential medical uses of psychedelic drugs including psilocybin and MDMA. The legislation, Senate Bill 166, was introduced earlier this month by Democratic state Senator Forrest Dunbar.</p>



<p class="wp-block-paragraph">If passed by the legislature and signed into law by Republican Governor Mike Dunleavy,&nbsp;<a href="https://www.akleg.gov/basis/Bill/Detail/33?Root=SB%20166" target="_blank" rel="noopener">Dunbar’s bill</a>&nbsp;would establish a task force that would be given one year to study how psychedelics might be used to address Alaska’s mental health challenges. The task force would investigate paths to legalize psychedelics, requirements for licensing and insurance, and barriers to access to the drugs.</p>



<p class="wp-block-paragraph">“We want Alaska to have a regulatory framework to potentially allow medical providers to use the substances, which had been shown in sort of the early data of the tests to potentially have really positive impacts on people dealing with trauma and with addiction,”&nbsp;<a href="https://alaskapublic.org/2024/01/26/psychedelic-medicine-task-force-would-lay-groundwork-for-therapeutic-use-in-alaska/" target="_blank" rel="noopener">Dunbar said</a>&nbsp;in a statement, according to a report from Alaska Public Media.&nbsp;</p>



<p class="wp-block-paragraph">The <a href="https://organickushfarm.com/product/penis-envy-mushroom/">psychedelics</a> task force created by the legislation would consist of people representing the healthcare needs of Alaska Natives, military veterans and survivors of domestic abuse and sexual assault. Dunbar said it is important to include Alaska Natives in the task force, noting that other states have not included representation of Indigenous communities and traditional healers in their discussions about psychedelics policy reform.</p>



<p class="wp-block-paragraph">Dunbar introduced Senate Bill 166 in anticipation of a potential change in the legal status of psychedelic drugs at the federal level. Clinical research and other studies into psychedelics such as psilocybin and MDMA have shown that the drugs have potential therapeutic benefits, particularly for serious mental health conditions such as&nbsp;<a href="https://www.forbes.com/sites/brucelee/2022/04/12/new-evidence-that-psilocybin-may-rewire-brain-to-help-those-with-depression/" target="_blank" rel="noopener">depression</a>, PTSD, substance misuse disorders and&nbsp;<a href="https://www.forbes.com/health/mind/what-is-anxiety/" target="_blank" rel="noopener">anxiety</a>.&nbsp;</p>



<p class="wp-block-paragraph">“It doesn’t work for everyone, but there are certainly people who could access these substances and potentially have life changing medical results,” Dunbar said.</p>



<h2 class="wp-block-heading" id="psychedelic-research-shows-promise"><strong>Psychedelic Research Shows Promise</strong></h2>



<p class="wp-block-paragraph">Research published in the peer-reviewed journal JAMA Psychiatry in 2020 found that psilocybin-assisted psychotherapy was an effective and quick-acting treatment for a group of 24 participants with major depressive disorder. A separate&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/" target="_blank" rel="noopener">study</a>&nbsp;published in 2016 determined that psilocybin treatment produced substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer.</p>



<p class="wp-block-paragraph">In 2017, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for psychotherapy utilizing MDMA, the psychedelic drug commonly known as Ecstasy, indicating that the therapy is a significant improvement over existing treatments. Last month, MAPS Public Benefit Corporation (MAPS PBC), a subsidiary of the groundbreaking psychedelics nonprofit advocacy group the Multidisciplinary Association for Psychedelic Studies (<a href="http://www.maps.org/" target="_blank" rel="noopener">MAPS</a>), announced it had submitted an application seeking FDA approval for MDMA-assisted therapy. Only weeks later, the organization announced it had changed its name to Lykos Therapeutics and had raised $100 million in financing to develop psychedelic therapies.</p>



<p class="wp-block-paragraph">As the research continues, Dunbar said it is important to address psychedelics policy including current prohibition and potential legalization so the drugs will be available to people who can benefit from them.</p>



<p class="wp-block-paragraph">“The hope is because these are <a href="https://organickushfarm.com/product/enigma-mushroom/">medical</a> treatments that we would find a way to bill insurance like anything else,” Dunbar said. “How do we make sure we can bill Medicaid and bill private insurance? And I know the indigenous community in particular needs to think about, and will help guide the task force, so that we can make sure we’re getting funds into the traditional healers’ hands as well.”</p>



<p class="wp-block-paragraph">Melissa Bradley, an epidemiologist based in Anchorage who studies psychedelic medicines, said that she became interested in the field after seeing the strong research data. She notes that psychedelic therapy is not an easy undertaking. Many patients find the experience challenging or upsetting during treatment, but long-lasting improvements in mental health have been reported for many patients.&nbsp;</p>



<p class="wp-block-paragraph">Most research into the therapeutic potential of psychedelics is conducted in a controlled environment. Although the method is effective, finding ways to use the drugs in other, less controlled settings could be the key to greatly expanding access to <a href="https://organickushfarm.com/product/albino-penis-envy/">psychedelic</a> therapy. </p>



<p class="wp-block-paragraph">“To really figure out the mystery of psychedelics is figuring out the mysteries of consciousness,” Bradley said. “And, we’re kind of poking at that, on the research side of things, but it’s also moving forward, in terms of policy. And so, it will be kind of a Wild West in terms of policy and regulations.”</p>



<p class="wp-block-paragraph">Dunbar’s bill has been referred to the Senate Labor and Commerce Committee for consideration. Democratic State Representative Jennifer Armstrong has filed&nbsp;<a href="https://www.akleg.gov/basis/Bill/Detail/?Root=HB%20228" target="_blank" rel="noopener">companion legislation</a>&nbsp;to Senate Bill 166 in the Alaska House of Representatives, where the measure has been assigned to the Health and Social Services Committee. No hearings have yet been planned for the bills, but Dunbar said he hopes to have one scheduled for early February.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://organickushfarm.com/psilocybin/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Arizona Bill Would Legalize Psilocybin Service Centers, Add to Current Research Efforts</title>
		<link>https://organickushfarm.com/psychedelic-therapy/</link>
					<comments>https://organickushfarm.com/psychedelic-therapy/#respond</comments>
		
		<dc:creator><![CDATA[eazecannabisdelivery]]></dc:creator>
		<pubDate>Sun, 27 Oct 2024 06:40:00 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[psilocybin]]></category>
		<category><![CDATA[Psilocybin service centers]]></category>
		<category><![CDATA[psychedelic research]]></category>
		<category><![CDATA[psychedelic therapy]]></category>
		<guid isPermaLink="false">http://organickushfarm.com/?p=4332</guid>

					<description><![CDATA[As Arizona lawmakers fight to extend psilocybin research deadlines, bipartisan leaders have introduced new legislation that would legalize psilocybin service centers in the state. As Arizona lawmakers push for increased psilocybin research, some are looking to take things a step further by joining the ranks of other states that have ushered in legal&#160;psilocybin&#160;therapy. A group [...]]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">As Arizona lawmakers fight to extend psilocybin research deadlines, bipartisan leaders have introduced new legislation that would legalize psilocybin service centers in the state.</p>



<p class="wp-block-paragraph">As Arizona lawmakers push for increased psilocybin research, some are looking to take things a step further by joining the ranks of other states that have ushered in legal&nbsp;<a href="https://hightimes.com/psychedelics/study-microdosing-psilocybin-may-help-treat-compulsive-behaviors-anhedonia/" target="_blank" rel="noopener">psilocybin</a>&nbsp;therapy.</p>



<p class="wp-block-paragraph">A group of nine bipartisan lawmakers in the state are sponsoring the newly introduced bill which would legalize psilocybin service centers, allowing those in Arizona to undergo therapy with the psychedelic substance under medical supervision, according to a&nbsp;<a href="https://www.marijuanamoment.net/arizona-lawmakers-file-bill-to-legalize-psilocybin-service-centers-as-state-funds-psychedelics-research/" target="_blank" rel="noopener"><em>Marijuana Moment</em>&nbsp;report</a>.&nbsp;</p>



<h2 class="wp-block-heading" id="arizonas-proposed-therapeutic-psilocybin-program"><strong>Arizona’s Proposed Therapeutic Psilocybin Program</strong></h2>



<p class="wp-block-paragraph"><a href="https://apps.azleg.gov/BillStatus/BillOverview/81143" target="_blank" rel="noopener">The bill</a> would allow the Department of Human Services (DHS) to license these centers and would also establish the Arizona Psilocybin Advisory Board. The board would include members appointed by the governor and legislative leaders, like representatives of the attorney general’s office and DHS, military veterans, first responders, scientists with psilocybin experience and physicians, among other potential groups. psychedelic research</p>



<p class="wp-block-paragraph">Following in the footsteps of other states that have legalized psilocybin therapy, the board would need to establish training criteria for those working in psilocybin service centers and would also make recommendations on how the law is implemented while studying the science and policy developments related to psilocybin and other psychedelics.</p>



<p class="wp-block-paragraph">Board members would also be required to submit an annual report by July 31, 2025 and each year after regarding the status of “medical, psychological and scientific” studies surrounding the safety and efficacy of psilocybin. Members would also be required to report on a “long-term strategic plan” to ensure psychedelic-assisted therapy remains “safe, accessible and affordable” to those over 21.</p>



<p class="wp-block-paragraph">Medical directors of the therapy centers would be required to complete at least 132 hours of training under the approved program, including lessons on the historical and traditional use of psychedelics, safety and ethics, facilitation and preparation, administration and integration.&nbsp;</p>



<p class="wp-block-paragraph">If passed, it would likely still be some time before Arizonans could expect to utilize the psilocybin services, however — the bill notes that the DHS would need to start accepting applications for the centers by Jan. 1, 2026. While the DHS would need to create rules for the program, the department would not be allowed to require specific <a href="https://organickushfarm.com/product/penis-envy-mushroom/">eligible</a> conditions for the services.</p>



<h2 class="wp-block-heading" id="adding-to-current-psilocybin-research-legislation"><strong>Adding to Current Psilocybin Research Legislation</strong></h2>



<p class="wp-block-paragraph">The bill would also provide a significant boost to the state’s existing law focused on psilocybin research.</p>



<p class="wp-block-paragraph">Last year, the research was approved as part of an appropriations package specifically mandating further study into the medical potential of psilocybin pertaining to conditions like post-traumatic stress disorder (PTSD), depression, anxiety, long COVID symptoms and substance misuse disorder.</p>



<p class="wp-block-paragraph">The legislation puts $5 million in funding toward the research, and unlike many other previous studies, Arizona’s prospective research would not utilize lab-produced psilocybin. Rather, it would look at the use of whole <a href="https://organickushfarm.com/product/albino-penis-envy/">mushrooms</a>.</p>



<p class="wp-block-paragraph">More recently, an Arizona House committee approved another bill meant to protect the funding from being redistributed while the state deals with a budget deficit. Passing in an 11-3 vote, the legislation keeps the psychedelic research funds from going elsewhere until at least July 2026 so long as it gains final approval. psychedelic research</p>



<p class="wp-block-paragraph">Without the new legislation, research appropriations were set to expire this summer, which advocates argued was not enough time to properly conduct the research.</p>



<p class="wp-block-paragraph">Without the deadline extension, Dr. Dani Cabral, the principal investigator at IMA Clinical Research,&nbsp;<a href="https://www.queencreektribune.com/news/psychedelic-mushroom-study-takes-step-forward-in-house/article_694c5bb6-bca4-11ee-98eb-7bd1fcd80447.html" target="_blank" rel="noopener">said</a>, “We are in a position here where we have $5 million, and few researchers will be awarded these funds, and they will have four months to complete a random control trial.”</p>



<p class="wp-block-paragraph">Sponsor Rep. Kevin Payne (R) similarly chimed in, pointing out that the research under the current timeline is essentially not possible.</p>



<p class="wp-block-paragraph">“What’s going to happen is they’re going to be halfway through the study and the money is going to run out and they’re not going to get paid at all,” he said. “So there won’t be anybody doing any studies unless we get this bill done.”</p>



<p class="wp-block-paragraph"><a href="https://hightimes.com/author/keegan-william/" target="_blank" rel="noopener"></a></p>
]]></content:encoded>
					
					<wfw:commentRss>https://organickushfarm.com/psychedelic-therapy/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>